fluorodeoxyglucose f18 has been researched along with Autoimmune Pancreatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akazawa, Y; Hiramatsu, K; Matsuda, H; Naito, T; Nakamoto, Y; Nosaka, T; Ofuji, K; Ohtani, M; Ozaki, Y; Saito, Y; Takahashi, K | 1 |
| Cheng, C; Li, M; Liu, Z; Peng, Y; Ren, S; Shen, J; Sun, G; Yang, X; Yang, Z; Zuo, C | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Autoimmune Pancreatitis
| Article | Year |
|---|---|
Clinical Usefulness of [18F]-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography for Distinguishing Between Autoimmune Pancreatitis and Pancreatic Cancer.
Topics: Aged; Autoimmune Pancreatitis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2021 |
Radiomics model of dual-time 2-[
Topics: Autoimmune Pancreatitis; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |